title: Targeting Stem Cells in Chronic Myeloid Leukemia with a PPAR-γ Agonist.
abstract: Combining a tyrosine kinase inhibitor (imatinib) and a thiazolidinedione (pioglitazone) is proposed for the treatment of chronic myeloid leukemia.
authors.forename: Josephine M
authors.initials: JM
authors.lastname: Egan
mesh_terms: D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D047495:PPAR gamma / Q000819:agonists*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D013234:Stem Cells / Q000187:drug effects
chemical_list: D047495:PPAR gamma; D047428:Protein Kinase Inhibitors; D000068877:Imatinib Mesylate